DePuy Synthes Procedure Recovery Offset by China Disruption

DePuy Synthes reported 4Q22 orthopedic sales of $2.1 billion, -0.4% compared to the fourth quarter of 2021. For the full-year 2022, the company amassed orthopedic sales of $8.6 billion, flat against the year prior.

Procedure volumes in the U.S. improved during the fourth quarter. DePuy Synthes’ 4Q22 hip replacement sales of $250 million...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us